Literature DB >> 28787238

β1-integrin-matrix interactions modulate cerebral microvessel endothelial cell tight junction expression and permeability.

Yoshikane Izawa1,2, Yu-Huan Gu1, Takashi Osada1,2, Masato Kanazawa1,3, Brian T Hawkins1,4, James A Koziol5, Thalia Papayannopoulou1, Maria Spatz6, Gregory J Del Zoppo1,7.   

Abstract

Acutely following focal cerebral ischemia disruption of the microvessel blood-brain barrier allows transit of plasma proteins into the neuropil as edema formation that coincides with loss of microvessel endothelial β1-integrins. We extend previous findings to show that interference with endothelial β1-integrin-matrix adhesion by the monoclonal IgM Ha2/5 increases the permeability of primary cerebral microvascular endothelial cell monolayers through reorganization of claudin-5, occludin, and zonula occludens-1 (ZO-1) from inter-endothelial borders. Interference with β1-integrin-matrix adhesion initiates F-actin conformational changes that coincide with claudin-5 redistribution. β1-integrin-matrix interference simultaneously increases phosphorylation of myosin light chain (MLC), while inhibition of MLC kinase (MLCK) and Rho kinase (ROCK) abolishes the Ha2/5-dependent increased endothelial permeability by 6 h after β1-integrin-matrix interference. These observations are supported by concordant observations in the cortex of a high-quality murine conditional β1-integrin deletion construct. Together they support the hypothesis that detachment of β1-integrins from abluminal matrix ligands increases vascular endothelial permeability through reorganization of tight junction (TJ) proteins via altered F-actin conformation, and indicate that the β1-integrin-MLC signaling pathway is engaged when β1-integrin detachment occurs. These findings provide a novel approach to the research and treatment of cerebral disorders where the breakdown of the blood-brain barrier accounts for their progression and complication.

Entities:  

Keywords:  Cerebral microvessel endothelium; intracellular signaling; permeability; tight junction proteins; β1-integrin

Mesh:

Substances:

Year:  2017        PMID: 28787238      PMCID: PMC5888854          DOI: 10.1177/0271678X17722108

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  67 in total

1.  Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells.

Authors:  Hung Hsuchou; Abba J Kastin; Hong Tu; N Joan Abbott; Pierre-Olivier Couraud; Weihong Pan
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

Review 2.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

3.  Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).

Authors:  Angela Graness; Klaudia Giehl; Margarete Goppelt-Struebe
Journal:  Cell Signal       Date:  2005-06-20       Impact factor: 4.315

4.  Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions.

Authors:  Mira Lischper; Simon Beuck; Gokulan Thanabalasundaram; Christian Pieper; Hans-Joachim Galla
Journal:  Brain Res       Date:  2010-03-01       Impact factor: 3.252

5.  Cathepsin L acutely alters microvessel integrity within the neurovascular unit during focal cerebral ischemia.

Authors:  Yu-Huan Gu; Masato Kanazawa; Stephanie Y Hung; Xiaoyun Wang; Shunichi Fukuda; James A Koziol; Gregory J Del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-22       Impact factor: 6.200

6.  Microglial cell activation is a source of metalloproteinase generation during hemorrhagic transformation.

Authors:  Gregory J del Zoppo; Harald Frankowski; Yu-Huan Gu; Takashi Osada; Masato Kanazawa; Richard Milner; Xiaoyun Wang; Naohisa Hosomi; Takuma Mabuchi; James A Koziol
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-22       Impact factor: 6.200

7.  Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons.

Authors:  G J del Zoppo; G W Schmid-Schönbein; E Mori; B R Copeland; C M Chang
Journal:  Stroke       Date:  1991-10       Impact factor: 7.914

8.  Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.

Authors:  Bharath Chelluboina; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Raghu Vemuganti; Krishna Kumar Veeravalli
Journal:  Stroke       Date:  2015-11-03       Impact factor: 7.914

Review 9.  Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.

Authors:  Helga E de Vries; Gijs Kooij; Dan Frenkel; Spiros Georgopoulos; Alon Monsonego; Damir Janigro
Journal:  Epilepsia       Date:  2012-11       Impact factor: 5.864

10.  Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion.

Authors:  G F Hamann; Y Okada; R Fitridge; G J del Zoppo
Journal:  Stroke       Date:  1995-11       Impact factor: 7.914

View more
  22 in total

Review 1.  Angiogenesis in the ischemic core: A potential treatment target?

Authors:  Masato Kanazawa; Tetsuya Takahashi; Masanori Ishikawa; Osamu Onodera; Takayoshi Shimohata; Gregory J Del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-06       Impact factor: 6.200

2.  Materials for blood brain barrier modeling in vitro.

Authors:  Magali P Ferro; Sarah C Heilshorn; Roisin M Owens
Journal:  Mater Sci Eng R Rep       Date:  2020-01-06       Impact factor: 36.214

Review 3.  Cell-specific expression and function of laminin at the neurovascular unit.

Authors:  Abhijit Nirwane; Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2022-07-07       Impact factor: 6.960

4.  Perlecan Improves Blood Spinal Cord Barrier Repair Through the Integrin β1/ROCK/MLC Pathway After Spinal Cord Injury.

Authors:  Changnan Xie; Yihan Wang; Jinfeng Wang; Yizhou Xu; Haining Liu; Jiasong Guo; Lixin Zhu
Journal:  Mol Neurobiol       Date:  2022-10-10       Impact factor: 5.682

5.  An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family.

Authors:  Céline Cegarra; Béatrice Cameron; Catarina Chaves; Tarik Dabdoubi; Tuan-Minh Do; Bruno Genêt; Valérie Roudières; Yi Shi; Patricia Tchepikoff; Dominique Lesuisse
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

6.  Pericyte-to-endothelial cell signaling via vitronectin-integrin regulates blood-CNS barrier.

Authors:  Swathi Ayloo; Christopher Gallego Lazo; Shenghuan Sun; Wei Zhang; Bianxiao Cui; Chenghua Gu
Journal:  Neuron       Date:  2022-03-15       Impact factor: 18.688

7.  Intracerebral hemorrhage and thrombin-induced alterations in cerebral microvessel matrix.

Authors:  Yu-Huan Gu; Brian T Hawkins; Yoshikane Izawa; Yoji Yoshikawa; James A Koziol; Gregory J Del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2022-05-05       Impact factor: 6.960

Review 8.  Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models.

Authors:  Midrelle E Noumbissi; Bianca Galasso; Monique F Stins
Journal:  Fluids Barriers CNS       Date:  2018-04-23

Review 9.  Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia.

Authors:  Feixue Wang; Yu Cao; Lina Ma; Hui Pei; Wolf Dieter Rausch; Hao Li
Journal:  Front Aging Neurosci       Date:  2018-11-16       Impact factor: 5.750

Review 10.  Rho-Associated Coiled-Coil Kinase (ROCK) in Molecular Regulation of Angiogenesis.

Authors:  Jing Liu; Youichiro Wada; Mari Katsura; Hideto Tozawa; Nicholas Erwin; Carolyn M Kapron; Gang Bao; Ju Liu
Journal:  Theranostics       Date:  2018-11-26       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.